Inhibitory effect of curcumin on proliferation of K562 cells involves down-regulation of p210bcr/abl-initiated Ras signal transduction pathway

Acta Pharmacologica Sinica

Volumn 24, Issue 11, 2003, Pages 1155-1160+1175

  Wu, Li Xian ^a   Xu, Jian Hua ^a   Wu, Guo Hua ^a   Chen, Yuan Zhong ^b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b Fujian Institute of Hematology   (China)

Author keywords

Bcr Abl fusion proteins; Curcumin; K562 cells; Signal transduction

Indexed keywords

ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; CURCUMIN; ETOPOSIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROTEIN; PROTEIN C JUN; RAS PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; CURCUMIN; DOWN-REGULATION; FUSION PROTEINS, BCR-ABL; GENES, RAS; HL-60 CELLS; HUMANS; K562 CELLS; SIGNAL TRANSDUCTION;

EID: 0242473876     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Martins LM, Mesner PW, Kottke TJ, Basi GS, Sinha S, Tung JS, et al. Comparision of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood 1997; 90: 4283-96.
2. Liao S, Lin J, Dang MT, Zhang H, Kao YH, Fukuchi J, et al. Growth suppression of hamaster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid. Arch Dermatol Res 2001; 293: 200-5.
3. Ammon HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991; 57: 1-7.
4. Kuttan R, Bhanumathy P, Nirmala K, Conney A.H. Potential anticancer active of turmeric (Curcuma longa). Cancer Lett 1985; 29: 197-203.
5. Korutla L, Kumar R. Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Brochim Biophys Acta 1994; 1224: 597-600.
6. Lin JK, Pan MH, Lin-Shiau SY. Recent studies on the biofunctions and biotransformations of curcumin. Biofactors 2000; 13: 153-8.
7. Jiang MC, Yang-Yen HF, Yen JJ, Lin JK. Curcumin induces apoptosis in immortalized NIH3T3 and maligant cancer cell lines. Nutr Cancer 1996; 26: 111-20.
8. bcr-abl Transformation of Murine Myeloid Cells. Blood 1993; 82: 1838-47.
9. Cortez D, Stoica G, Pierce JH, Pendergast AM. The BCR/ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway. Oncogene 1996; 13: 2589-94.
10. bcr/abl protein in human chronic myelogenous leukemia K562 cells. FASEB J 2000; 14: A1516.
11. Squires MS, Hudson EA, Howells L, Sale S, Houghton CE, Jones JL, et al. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem Pharmacol 2003; 65: 361-76.
12. Qian J, Zhou CH, Qian Z, Nan FJ, Ye QZ. Development of a K562 cell-based assay for screening anticancer agents. Acta Pharmacol Sin 2001; 22: 821-6.
13. Catovsky D. Ph-1 positive acute leukaemia and chronic granulocytic leukaemia: one or two diseases? Br J Haematol 1979; 42: 493-8.
14. Hermans A, Heisterkamp N, Von Lindern M. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukaemia. Cell 1987; 51: 33-40.
15. Wu YD, Chen Y, He J, Chen WJ, Li HY, Xiang JP, et al. The study of the effect of curcumin on apoptosis-regulating protein Mcl-1, Bax and Bak in acute myeloid leukemia HL-60 cell line. Acta Univ Med Tongji 2001; 30: 25-7.